InMed Pharmaceuticals (INM) Treasury Shares (2023 - 2026)

InMed Pharmaceuticals has reported Treasury Shares for 4 years, with the latest figure at $3.5 million in Q1 2026.

• For the quarter ending Q1 2026, Treasury Shares rose 8188.7% year-over-year to $3.5 million; the trailing twelve-month figure through Mar 2026 stood at $3.5 million (up 8188.7% YoY), and the FY2025 full-year result was $4.5 million, up 734.35% from the prior year.
• Treasury Shares for Q1 2026 stood at $3.5 million, down from $3.7 million in the prior quarter.
• The five-year high for Treasury Shares was $13.2 million in Q1 2024, with the low at $42096.0 in Q1 2025.
• Historically, Treasury Shares has averaged $2.8 million across 4 years, with a median of $559267.0 in 2023.
• Annual changes were most pronounced in 2025 — Treasury Shares sank 99.68% — and 2026, when it surged 8188.7%.
• InMed Pharmaceuticals' Treasury Shares stood at $559267.0 in 2023, then plunged by 91.56% to $47176.0 in 2024, then jumped by 7826.09% to $3.7 million in 2025, then dropped by 6.69% to $3.5 million in 2026.
• The last three Treasury Shares figures came in at $3.5 million (Q1 2026), $3.7 million (Q4 2025), and $3.9 million (Q3 2025), per Business Quant data.